Senseonics (SENS) “announced a mutually executed Memorandum of Understanding to transition all commercialization and distribution of Eversense 365 and future products from Ascensia Diabetes Care, a member of PHC Group, to Senseonics. By unifying the Eversense business and incorporating commercial activities directly within Senseonics, the companies believe Eversense would achieve accelerated growth and realize its full potential faster than under the current structure.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SENS:
- Senseonics initiated with an Overweight at Barclays
- Senseonics (SENS) Earnings Call Highlights Growth and Future Plans
- Senseonics Holdings: Strong Financial Performance and Strategic Initiatives Drive Buy Rating
- Senseonics Holdings Reports Strong Q2 Revenue Growth
- Senseonics reports Q2 EPS (2c), consensus (2c)
